Insys Therapeutics to Present at Jefferies 2015 Healthcare Conference
(firmenpresse) - PHOENIX, AZ -- (Marketwired) -- 05/20/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that Michael L. Babich, President and Chief Executive Officer, and Darryl Baker, Chief Financial Officer, will present at the Jefferies 2015 Healthcare Conference as follows:
Conference: Tuesday, June 2, 2015
Time: 11:00 a.m. EDT
The presentation will be webcast live at the aforementioned time as well as archived for 90 days thereafter, via the Company''s website at , under the Investors Section.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets two products, Subsys®, which is sublingual Fentanyl spray for breakthrough cancer pain, and a generic version of Dronabinol (THC) capsules. The Company''s lead product candidate is Dronabinol Oral Solution, a proprietary, orally administered liquid formulation of dronabinol that Insys believes has distinct advantages over the current formulation of dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual sprays, as well as pharmaceutical cannabidiol.
Subsys® is a registered trademark of Insys Therapeutics, Inc.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.05.2015 - 05:30 Uhr
Sprache: Deutsch
News-ID 1360112
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PHOENIX, AZ
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insys Therapeutics to Present at Jefferies 2015 Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Insys Therapeutics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
